{
  "figure_1": "Quality of life in long-term survivors of different types of blood cancer at the time of the survey, as assessed by the EORTC QLQ C-30 (global health status, functioning, symptoms) and HADS questionnaires (depression). The results of the HADS anxiety scale (not shown) were similar to those of the depression scale. MGUS monoclonal gammopathy of undetermined significance, 16 responding survivors, MM multiple myeloma, 37 survivors, iNHL/CLL indolent non-Hodgkin lymphoma/chronic lymphocytic leukemia, 254 survivors, MPN/CML myeloproliferative neoplasm/chronic myeloid leukemia, 106 survivors, MDS myelodysplastic syndrome, 5 survivors, aNHL/HL aggressive non-Hodgkin lymphoma/Hodgkin lymphoma, 481 survivors, AML/ALL acute myeloid leukemia/acute lymphoblastic leukemia, 74 survivors, AlloTx allogeneic transplantation, 547 survivors. Box, range between the 25th and 75th percentile; whiskers, upper quartile with maximum and lower quartile with minimum, respectively; horizontal line, median; diamond, mean.",
  "figure_2": "Quality of life in long-term blood cancer survivors at the time of the survey in relation to the duration of follow-up, as assessed by the EORTC QLQ C-30 (global health status, functioning, symptoms) and HADS questionnaires (depression). The results of the HADS anxiety scale (not shown) were similar to those of the depression scale. Follow-up 4–5 years, 284 responding survivors; 6–10 years, 516 survivors; > 10 years, 720 survivors. Box, range between the 25th and 75th percentile; whiskers, upper quartile with maximum and lower quartile with minimum, respectively; horizontal line, median; diamond, mean."
}